Identifying determinants of pathologic complete response in patients with breast cancer after receiving neoadjuvant systemic therapy

被引：0
|
作者：
Chan, Abigail Sy
Bhargava, Anika
Chandler, Natasha
Tavcar, Michelle
Gunaratnam, Bakeerathan
Dong, Brian
机构：
[1] Univ Louisville, Louisville, KY USA
[2] Univ Louisville, Sch Med, Louisville, KY USA
[3] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12622
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Assessment of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Systemic Therapy
    Farrukh, Nida
    Bano, Razia
    Naqvi, Syeda Rifaat Qamar
    Latif, Humera
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 746 - 750
  • [2] Demographic Determinants of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
    Anderson, Lisa
    Daniele, Karla
    Hayes, Madison
    Dancel, Canice Lei
    Dhanasekara, Samudani
    Rahman, Rakhshanda
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S383 - S384
  • [3] Parsing Pathologic Complete Response in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer
    Morrow, Monica
    JAMA ONCOLOGY, 2016, 2 (04) : 516 - 517
  • [4] Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers
    Myers, Sara P.
    Sevilimedu, Varadan
    Barrio, Andrea V.
    Tadros, Audree B.
    Mamtani, Anita
    Robson, Mark E.
    Morrow, Monica
    Lee, Minna K.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [5] The effects of metformin on pathologic complete response (pCR) rates in diabetic breast cancer (BC) patients receiving neoadjuvant systemic therapy (NST)
    Jiralerspong, S.
    Giordano, S. H.
    Meric-Bernstam, F.
    Barnett, C. M.
    Kau, S.
    Hung, M. C.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings
    von Minckwitz, Gunter
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 779 - 780
  • [7] Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings
    Gunter von Minckwitz
    Breast Cancer Research and Treatment, 2012, 132 : 779 - 780
  • [8] Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers.
    Myers, Sara P.
    Sevilimedu, Varadan
    Barrio, Andrea Veronica
    Tadros, Audree
    Mamtani, Anita
    Robson, Mark E.
    Morrow, Monica
    Lee, Minna
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] The Accuracy of MRI in Predicting Pathologic Complete Response in Invasive Breast Cancer Patients Receiving Neoadjuvant Systemic Treatment.
    De Los Santos, J.
    Bernreuter, W.
    Keene, K.
    Krontiras, H.
    Carpenter, J.
    Bland, K.
    Cantor, A.
    Forero, A.
    CANCER RESEARCH, 2009, 69 (24) : 713S - 714S
  • [10] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Mueller, Carolin
    Schmidt, Gilda
    Juhasz-Boess, Ingolf
    Jung, Lisa
    Huwer, Sarah
    Solomayer, Erich-Franz
    Juhasz-Boess, Stephanie
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1065 - 1071
12345